Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
- Posted on June 16, 2026
- By CNBC
- 0 Views
- 1 min read
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.
